European Cerebral Oximeters Market Research Report
- Report Code: CE 1003
- Publish Date: Upcoming
The European cerebral oximeter device market is driven by cardiac/vascular surgery, shoulder surgery, single lung ventilation, and other surgical procedures. The market was valued at $19.7 million in 2013, and is estimated to reach $27.3 million by 2018, at a CAGR of 6.7%. Germany is the largest market for cerebral oximeter devices in Europe, followed by France and Italy. The European region offers a huge untapped market for these devices, due to the rising awareness of neurological disorders, increase in purchasing power, and an upsurge observed in a large number of individuals suffering from multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s, and Alzheimer’s disease.
The report, ‘European Cerebral Oximeters Devices Market Forecast, 2012-2018’, analyzes the market in terms of its end-user applications. With a market value of $0.08 billion, the cerebral oximeter market has accounted for 8%-10% in terms of value, towards the total brain monitoring device industry. The cerebral oximeter market has been witnessing maximum growth, owing to the rapid demand of highly sophisticated neurological procedures, and increase in the patient pool.
In addition to aforementioned factors, incessant rise in the post-surgical cerebrovascular accidents has triggered the demand for enhanced and automated brain monitoring devices, thereby acting as a significant driver for this market. These brain monitoring devices are being hugely incorporated in hospitals as well as clinics to assess the activity of sedatives and anesthesia. According to the estimates provided by WHO, in 2011, the global prevalence of epilepsy and multiple sclerosis was calculated at 50 million and 2.5 million, respectively.
This report delivers insightful information on the market share of major companies, value chain analysis, and varied market dynamics, including drivers, restraints, and upcoming opportunities. It also offers a competitive landscape of key market players, along with details on their product portfolio, recent developments, and growth strategies. The prominent players covered in this report are Covidien plc (Ireland), Nonin Medical, Inc. (U.S.), and CAS Medical Systems, Inc. (U.S.). The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of major companies have also been covered in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in accordance with your company’s specific needs. Customize your report on the European market for cerebral oximeter devices to get an insight into an all-inclusive industry standards and deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix, which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence, incidence, and mortality rate of multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s disease, and Alzheimer’s disease
- Country-specific patient pool of multiple sclerosis, epilepsy, cerebrovascular diseases, Parkinson’s disease, Alzheimer’s diseases, and traumatic brain injuries
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of cardiac/vascular and surgeries performed annually in each country, tracked till sub-segment level
Surgeon’s/Physician’s Forum
- Fast turnaround analysis of surgeons’ response to market events and trends
- Pattern analysis of usage of cerebral oximeter devices by physicians
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool, by checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity, along with brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of cerebral oximeter devices in the European market
- Procedural investment in cardiac/vascular surgery, shoulder surgery, and single lung ventilation in the European market
Competitive Intelligence
- Company share analysis of top players in the European Cerebral Oximeter Device Market
- Crucial developments and strategies of companies operating in the cerebral oximeter devices market segment
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Brain Monitoring Devices The North American Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders which was valued at $1119.6 million in 2012 and is poised to grow at a CAGR of 9.0% to reach $1834.0 million by 2018. North American Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The major players extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
European Brain Monitoring Devices The European Brain monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The European Brain monitoring market was valued at $279.9 million in 2012 and is poised to grow at a CAGR of 8.6% to reach $458.5 million by 2018. The European Brain monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in Brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
|
|
Asian Brain Monitoring Devices The Asian Brain Monitoring Devices Market, mainly driven by rising incidences of autoimmune and cardiovascular diseases, brain disorders and sleep disorders. The Asian brain monitoring market was valued at $162.3 million in 2012 and is poised to grow at a CAGR of 9.2% to reach $275.1 million by 2018. The Asian Brain Monitoring Devices market segmented by product such as Electroencephalograph, Transcranial Doppler, Magnetoencephalograph, Intracranial Pressure Monitor, Cerebral Oximeter, and Acessories. The main companies operating in the Asian brain monitoring devices market and extensively covered in this report are Nihon Kohden Corporation, Nonin Medical Inc, Elekta AB, and Advanced Brain Monitoring, Inc., Yokogawa, Grass Technologies, Compumedics Ltd, Cadwell Laboratories |
Upcoming |
